Journal of Hospice and Palliative Care

Korean Society for Hospice and Palliative Care (한국호스피스완화의료학회)
권호 표지

Prognostic Value of Leptin in Terminally Ill Cancer Patients

말기암환자의 여명 예측 요인, 혈중 렙틴 농도의 효과

  • Hong, Ji-Hyun (Department of Family Medicine, Korea University College of Medicine) ;
  • Lee, So-Jin (Department of Family Medicine, Korea University College of Medicine) ;
  • Kwak, Sang-Mi (Department of Family Medicine, Korea University College of Medicine) ;
  • Choi, Youn-Seon (Department of Family Medicine, Korea University College of Medicine) ;
  • Lee, June-Yeong (Department of Biostatistics, Korea University College of Medicine)
  • 홍지현 (고려대학교 의과대학 가정의학교실) ;
  • 이소진 (고려대학교 의과대학 가정의학교실) ;
  • 곽상미 (고려대학교 의과대학 가정의학교실) ;
  • 최윤선 (고려대학교 의과대학 가정의학교실) ;
  • 이준영 (고려대학교 의과대학 의학통계학교실)
  • Received : 2012.02.18
  • Accepted : 2012.05.07
  • Published : 2012.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Most terminally ill cancer patients die from cancer anorexia-cachexia syndrome. This study evaluated a prognostic role of plasma leptin levels in terminally ill cancer patients. Methods: This study enrolled 69 terminally ill cancer patients who were aged above 20 years old from July 2009 to July 2010. For univariate analysis, an association between leptin levels and patient's characteristics or other variables was examined using Spearman's correlation analysis, Wilcoxon's rank-sum test or Kruskal-Wallis test, as appropriately. For multivariable analysis, Cox's proportional hazard regression model was used to evaluate a clinical significance of plasma leptin levels as a prognostic factor and to determine factors which affect the risk of death in terminally ill cancer patients. Results: A statistically significant positive correlation between plasma leptin levels and survival time was found. Univariate Cox's proportional hazard regression analyses also showed a moderately significant association between plasma leptin levels and survival time. However, after adjusting variables for sex, white blood cell counts, total bilirubin, AST, ALT, albumin and CRP levels, plasma leptin levels were not significantly associated with survival time. Conclusion: No significant association was found between plasma leptin levels and survival time in terminally ill cancer patients. However, this study suggested a prognostic value of plasma leptin levels in gastrointestinal cancer patients.

목적: 말기암환자의 여명 예측은 치료의 이득과 위해를 판단하는 잣대가 되고, 적절한 의료 중재 제공 및 환자의 자율성에 기초한 의사결정에 중요한 기준이 된다. 특히 많은 수의 말기암환자는 암성 식욕부진-악액질 증후군으로 사망에 이르기 때문에 본 연구에서는 이를 반영할 수 있는 혈장 렙틴 농도와 생존기간과의 연관성을 알아보고자 하였다. 방법: 2009년 7월부터 2010년 7월까지 13개월 동안, 만 20세 이상의 말기암환자 69명을 대상으로 혈장 렙틴 농도를 측정하고, 생존기간을 조사하였다. 나이, 성별, 원발암 부위, 암 치료 경력, 전이여부, 투약상황 및 활력증후, 백혈구 수, 혈색소, Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), C-반응성 단백질, 총 빌리루빈, 총 콜레스테롤, 알부민, 렙틴 등의 혈액검사를 시행하였다. 결과: 혈장 렙틴 농도와 성별, 나이, 백혈구 수, 혈색소, AST, ALT, 총 빌리루빈, C-반응성 단백질, 통증강도 등의 상관 관계 분석 결과 렙틴과 생존기간에는 통계적으로 유의한 양의 상관 관계를 보였으며, 단변량 분석한 결과 혈장 렙틴 농도는 생존기간과 통계적으로 경계수준의 유의한 관계를 보였으나, 단변량 분석에서 생존 기간에 유의한 영향을 미치는 성별, 백혈구 수, AST, ALT, 총 빌리루빈, 알부민, C-반응성 단백질을 포함하여 시행한 다변량 분석에서 혈장 렙틴 농도는 생존기간과 통계적으로 유의한 관계가 없는 것으로 나타났다. 결론: 암성 식욕부진-악액질 증후군과 관련이 있는 혈장 렙틴 농도와 말기암환자의 생존기간과는 통계적으로 유의한 연관성을 보이지는 않았다. 그러나, 소화기계암환자에 있어서는 혈장 렙틴 농도가 생존기간 예측인자로서 쓰일 수 있는 가능성을 보여주었다.

Keywords

References

  1. Statistics Korea. 2007 annual statistical report for cause of death. Daejeon:Statistics Korea;2008.
  2. den Daas N. Estimating length of survival in end-stage cancer: a review of the literature. J Pain Symptom Manage 1995;10:548-55. https://doi.org/10.1016/0885-3924(95)00103-6
  3. Larkin M. Thwarting the dwindling progression of cachexia. Lancet 1998;351:1336. https://doi.org/10.1016/S0140-6736(05)79068-1
  4. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997;315:1219-22. https://doi.org/10.1136/bmj.315.7117.1219
  5. Slaviero KA, Read JA, Clarke SJ, Rivory LP. Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 2003;46:148-57. https://doi.org/10.1207/S15327914NC4602_07
  6. Banks WA. The many lives of leptin. Peptides 2004;25:331-8. https://doi.org/10.1016/j.peptides.2004.02.014
  7. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998;18:399-419. https://doi.org/10.1046/j.1365-2281.1998.00129.x
  8. Morton GJ. Hypothalamic leptin regulation of energy homeostasis and glucose metabolism. J Physiol 2007;583:437-43. https://doi.org/10.1113/jphysiol.2007.135590
  9. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedmam JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-32. https://doi.org/10.1038/372425a0
  10. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural network. Science 1995;269:546-9. https://doi.org/10.1126/science.7624778
  11. Lee DH. Leptin-signal transduction pathway and relationship with cancer development. Korean J Gynecol Oncol 2007;18:67-92.
  12. Takahashi M, Terashima M, Takagane A, Oyama K, Fujiwara H, Wakabayashi G. Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs. Int J Clin Oncol 2009;14:315-20. https://doi.org/10.1007/s10147-008-0856-1
  13. Mantovani G, Maccio A, Madeddu C, Mura L, Gramignano G, Lusso MR, et al. Quantitive evaluation of oxidative stress, chronic inflammatory indices and leptin in cancer patients: correlation with stage and performance status. Int J Cancer 2002;98:84-91. https://doi.org/10.1002/ijc.10143
  14. Sato T, Meguid MM, Miyata G, Chen C, Hatakeyama K. Does leptin really influence cancer anorexia? Nutrition 2002;18:82-3. https://doi.org/10.1016/S0899-9007(01)00730-4
  15. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. NEJM 1996;334:292-5. https://doi.org/10.1056/NEJM199602013340503
  16. Moon SS, Jeon JH, Lee JE, Park SH, Kim HK, Doh JY, et al. Blood leptin, anthropometric and biochemical parameters in Type 2 diabetics. J Korean Diabetes Assoc 2007;31:75-82. https://doi.org/10.4093/jkda.2007.31.1.75
  17. Malyszko J, Malyszko JS, Pawlak K, Konstantynowicz J, Wolczynski S, Kaczmarski M, et al. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients. Transplant Proc 2005;37:2151-3. https://doi.org/10.1016/j.transproceed.2005.03.001